Last week we asked you, our readers, to decide which challenge was the most significant – science (our understanding of inflammation is not developed enough); consumers (they don’t understand inflammation); marketers (they don’t know how to communicate inflammation); or everything (inflammation will never be a mainstream health category).
As our chart below shows, of the 101 people who voted, 43.6 percent said that consumers will need educating before the sector can take off, while 30.7 percent think that the science is the rate-limiter for this market. (Articles continues with chart below ↓)
Our special edition on inflammation pooled opinion and insight from a host of industry personalities. We looked at the science behind anti-inflammatory ingredients, consumers’ (lack of) understanding, and the market potential of anti-inflammatory formulations.